David Morgenstern

David Morgenstern, PhD, serves as the Vice President of Clinical Development at DELFI Diagnostics, starting in May 2023. Prior to this role, David held various positions at Roche from April 2012 to May 2023, including Global Head of Clinical Development for Oncology & Genetics, where responsibilities included driving clinical development and implementing plans to produce clinical evidence on time and within budget. Previous experience includes serving as Director of Clinical Affairs at Endocyte and roles at Merck, Kelly Scientific, Physicians Research Group, and Wells Center for Pediatric Research. David holds a PhD in Microbiology and Immunology from Indiana University Indianapolis and has advanced training in Clinical Investigation from MGH Institute of Health Professions. David earned a BS in Biology from Binghamton University.